152 Epizód

  1. Medical Affairs Series, Part Five: Medical Affairs in the Early Stage

    Közzétéve: 2020. 01. 10.
  2. Real World Evidence and Rare Diseases

    Közzétéve: 2019. 12. 20.
  3. The Digital Therapeutics Alliance: A European Perspective

    Közzétéve: 2019. 12. 11.
  4. Medical Affairs Series, Part Four: Medical Affairs in the Field

    Közzétéve: 2019. 11. 20.
  5. Medical Affairs Series, Part Three: Moving to the Left

    Közzétéve: 2019. 11. 06.
  6. Advocacy Archetypes

    Közzétéve: 2019. 10. 24.
  7. Medical Affairs Series, Part Two - Measuring the Unmeasurable: Medical Affairs Metrics

    Közzétéve: 2019. 10. 09.
  8. Why We Resist

    Közzétéve: 2019. 09. 25.
  9. Medical Affairs Series, Part One: A Foundation for Medical Affairs

    Közzétéve: 2019. 09. 11.
  10. A Regulatory Roadmap for Real World Evidence

    Közzétéve: 2019. 08. 28.
  11. Talented Teams

    Közzétéve: 2019. 08. 14.
  12. Digital Therapeutics

    Közzétéve: 2019. 07. 31.
  13. Talking About PIE

    Közzétéve: 2019. 07. 17.
  14. MOAs in ONC: The Latest and Greatest in the Oncology Pipeline

    Közzétéve: 2019. 07. 03.
  15. Episode 037: Psychology in Clinical Trials

    Közzétéve: 2019. 06. 19.
  16. Episode 036: Commercialization for Emerging Companies

    Közzétéve: 2019. 06. 05.
  17. Episode 035: How Translational Science Can Solve Pharma's Productivity Puzzle

    Közzétéve: 2019. 05. 15.
  18. Episode 034: Can the Gut Microbiome Revolutionize Medical Care?

    Közzétéve: 2019. 05. 01.
  19. APAC Edition: Medical Affairs in China

    Közzétéve: 2019. 04. 26.
  20. Episode 033: From DTC to DT"Me" - The Future of Communications in Pharmaceuticals

    Közzétéve: 2019. 04. 17.

6 / 8

The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.

Visit the podcast's native language site